Clinical trial

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.

NCT05120973

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention multispectral imaging Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention fluorescence for lymphatic mapping Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-11-01

PhaseN/A

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

multispectral imagingPROCEDURE

fluorescence for lymphatic mappingPROCEDURE

Sponsors & collaborators

The Netherlands Cancer Institutelead sponsor

Mapped research locations

AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05120973 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.